Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Oncology Research Program (ORP) today announced new funding for advancing clinical research in Non-Small Cell Lung Cancers ...

A new study that found high levels of heavy metals in popular nicotine vapes adds to concerns about the products.

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major ...

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...